Search clinical trials for: Sitagliptin-placebo
Total 54381 results
-
Imperial College LondonCompleted
-
Johnson & Johnson Consumer and Personal Products...CompletedAndrogenetic AlopeciaUnited States
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Bulgaria, Czech Republic, Hungary, Poland
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
NovartisGenentech, Inc.; TanoxCompleted
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)Germany
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Daiichi Sankyo Co., Ltd.CompletedType2 Diabetes MellitusJapan
-
GlaxoSmithKlineCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of British ColumbiaTerminated
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Boehringer IngelheimCompleted
-
Bio-innova Co., LtdNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Johns Hopkins UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted
-
COMPASS PathwaysRecruitingTreatment Resistant DepressionUnited States, Spain, Ireland, France, United Kingdom, Canada, Sweden
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Hungary, Taiwan, Romania, India, South Africa, Philippines, Slovakia
-
Sheikh Zayed Federal Postgraduate Medical InstituteCompletedDiabetes Mellitus | Randomized Controlled TrialPakistan
-
Nicolai Jacob Wewer AlbrechtsenCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Southern California College of Optometry at Marshall...RecruitingAqueous Tear Deficiency | Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)United States
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
IlDong Pharmaceutical Co LtdRecruiting
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Vanderbilt UniversityCompletedHypertension | Metabolic SyndromeUnited States
-
Usona InstituteWorldwide Clinical TrialsRecruiting
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Germany, United Kingdom, Austria
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus | Steroid Diabetes | Glucocorticoid-induced Diabetes | Beta-cell FunctionNetherlands
-
Michael A. NauckCompletedType 2 DiabetesGermany
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom